Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | Our next Cancer Prevention Research Conference will be in London in 2025, on 25-27 June. In its second edition, we’re hosting the event in collaboration with the American Cancer Society and the National Cancer Institute. Join us to hear from our keynote speakers Charles Swanton (The Francis Crick Institute), Elisabete Weiderpass (International Agency for Research on Cancer), Allan Balmain (University of California San Francisco) and a packed agenda of networking, panels and debate. Follow #PrevConf25 on social media and visit our website for speakers and programme updates.
|
| |
| |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | Applications accepted all year round |
|
---|
| | | | Applications accepted all year round |
|
---|
| | | | Applications accepted all year round |
|
---|
| | | | Applications accepted all year round |
|
---|
|
| |
|
|
“Pill-on-a-thread” cancer screening trial welcomes first participants |
| A trial has opened to investigate whether screening people with heartburn for Barrett's Oesophagus using a capsule sponge test could improve cancer outcomes. The BEST4 screening trial, co-directed by Rebecca Fitzgerald (University of Cambridge) and Peter Sasieni (Queen Mary University of London), aims to find out if the capsule sponge test could reduce the need for cancer treatments and prevent deaths from oesophageal cancer. Over the next three years, the trial will recruit 120,000 people who regularly take medication for heartburn – the most common symptom for Barrett’s oesophagus, a condition that can increase risk of oesophageal cancer. The initiative jointly funded by us and the National Institute for Health and Care Research, is the last step in a series of clinical trials to see if the capsule sponge test could be offered in cancer screening programmes across the UK.
|
| |
|
|
|
| | Are you interested in the biological mechanisms underlying both ageing and cancer development, and the translation of research into cancer primary prevention approaches? Join co-chairs Walid Khaled (University of Cambridge) and Professor Lynne Cox (University of Oxford) on 28 January for discussions about future directions for the field during a full day workshop. Join us in London at the Royal Society of Chemistry and contribute to generate new perspectives and collaborations for research projects.
| |
| | | | At our recent Brain Tumour Conference, Arnold Kriegstein sat down with us to talk about the important role developmental biology plays in shaping our understanding of brain cancers. Arnold’s lab at the University of California San Francisco has made significant contributions to our understanding of neural stem cells using some of the latest technologies to enter the lab. Hear from Arnold on how technologies like single cell transcriptomics, spatial transcriptomics and epigenomics are helping this field to move forward. Find out how the pace of lab tech evolution can present as a challenge when running a lab in one of the most exciting areas in brain cancer research.
| |
|
---|
|
|
|
|
Help shape environmentally sustainable cancer research |
| We need your help identifying current practices, challenges and opportunities for improving environmental sustainability in research. It’s becoming ever clearer that biomedical research has a considerable impact on the environment. Change is needed, even if that means altering the way we approach research and reviewing the practices that influence its environmental impact. We’re committed to delivering cutting-edge research more responsibly, and your views will help us to support our research community in adopting more sustainable methods and practices.
|
| |
|
|
|
| | HDRUK’s Black Internship Programme is an exciting initiative providing Black undergraduate and postgraduate students with hands-on experience in health data science. They’re now looking for new host organisations for the next year of the programme. By becoming a host organisation, you’ll have access to a diverse pool of talented interns and will engage with future leaders in health data research. You’ll be helping to diversify the health data workforce and will have the chance to network with other organisations within the health data sector. The internship period will run from 30 June – 22 August 2025, and HDRUK will provide support and guidance to both interns and host organisations throughout the internship. Find out more about what being a host entails. | |
| | | | Take the next step in your research career at the University of Oxford. Our Oxford Centre awards around 15 full-time, fully funded positions on the DPhil in Cancer Science Programme each year. There are four application tracks you can take to suit your background and career goals. Whether you’re a clinical student or trainee, a non-clinical scientist or a fundamental scientist, you can undertake advanced study into cancer research through this programme. Oxford is also participating in our Black Leaders in Cancer scholarship programme this year. Successful applicants will benefit from being a part of Oxford’s DPhil programme, as well as having access to mentoring, career support, leadership training and networking led by the Windsor Fellowship and Black in Cancer. | |
|
---|
|
|
|
|
| Together we are beating cancer |
| | |
---|
|
|
|
| You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here. Your details are safe with us. Check out our Privacy Policy. Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise. This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|